Zhu et al. studied clinical samples from CRC patients and found that EIF5A2 might be involved in CRC aggressiveness and that EIF5A2 increased the expression of MTA1 to induce EMT26. The gene discussed is EIF5A2; the disease is colorectal carcinoma.